Metropolis Healthcare’s arm to acquire Agra-based Scientific Pathology

03 Mar 2025 Evaluate

Metropolis Healthcare’s wholly owned subsidiary -- Metropolis Clinical Pathology is all set to acquire Agra-based Scientific Pathology through a Business Transfer Agreement (BTA). This strategic move strengthens Metropolis’ presence in Western Uttar Pradesh, accelerates its B2C expansion, and unlocks growth opportunities across the state and beyond.

Under the agreement, Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction. The consideration for the acquisition will range between Rs 55 crore and Rs 83 crore, determined at 12.2x of the adjusted EBITDA over a defined assessment period. The transaction will be executed through a Securities Subscription Cum Shareholders’ Agreement (SHA), backed by Metropolis Healthcare. Upon completion, Metropolis Clinical Pathology will transition from a wholly owned subsidiary while continuing to be an integral part of the Metropolis Healthcare Group.

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.

Metropolis Health. Share Price

1751.60 -11.30 (-0.64%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6951.85
Max Healthcare Inst 1068.00
Narayana Hrudayalay 1787.40
Aster DM Healthcare 505.25
Global Health 1214.75
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...